연구성과로 돌아가기
2024 연구성과별 연구자 정보 (1557 / 2344)
※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Document Title | Author Full Name | Author Short Name | Index | Corresponding | Address | ResearcherID | ResearcherID Author Name | ORCID | ORCID Author Name | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
| One-year clinical outcomes of switching to subcutaneous infliximab in patients with inflammatory bowel disease on maintenance of intravenous infliximab therapy with or without remission: A multicentre cohort study | Kim, K. O. | Kim, KO | 5 | Yeungnam Univ, Coll Med, Dept Internal Med, Daegu, South Korea | ||||||
| One-year clinical outcomes of switching to subcutaneous infliximab in patients with inflammatory bowel disease on maintenance of intravenous infliximab therapy with or without remission: A multicentre cohort study | Kim, E. S. | Kim, ES | 6 | CCAiD, Crohns & Colitis Assoc Daegu Gyeongbuk, Daegu, South Korea | ||||||
| One-year clinical outcomes of switching to subcutaneous infliximab in patients with inflammatory bowel disease on maintenance of intravenous infliximab therapy with or without remission: A multicentre cohort study | Kim, E. S. | Kim, ES | 6 | Kyungpook Natl Univ, Sch Med, Dept Internal Med, Daegu, South Korea | ||||||
| One-year clinical outcomes of switching to subcutaneous infliximab in patients with inflammatory bowel disease on maintenance of intravenous infliximab therapy with or without remission: A multicentre cohort study | Jo, H. H. | Jo, HH | 7 | CCAiD, Crohns & Colitis Assoc Daegu Gyeongbuk, Daegu, South Korea | ||||||
| One-year clinical outcomes of switching to subcutaneous infliximab in patients with inflammatory bowel disease on maintenance of intravenous infliximab therapy with or without remission: A multicentre cohort study | Jo, H. H. | Jo, HH | 7 | Daegu Catholic Univ, Sch Med, Dept Internal Med, Daegu, South Korea | ||||||
| One-year clinical outcomes of switching to subcutaneous infliximab in patients with inflammatory bowel disease on maintenance of intravenous infliximab therapy with or without remission: A multicentre cohort study | Hong, S. W. | Hong, SW | 8 | Univ Ulsan, Coll Med, Asan Med Ctr, Dept Gastroenterol & Internal Med, Seoul, South Korea | ||||||
| One-year clinical outcomes of switching to subcutaneous infliximab in patients with inflammatory bowel disease on maintenance of intravenous infliximab therapy with or without remission: A multicentre cohort study | Park, S. H. | Park, SH | 9 | Univ Ulsan, Coll Med, Asan Med Ctr, Dept Gastroenterol & Internal Med, Seoul, South Korea | ||||||
| One-year clinical outcomes of switching to subcutaneous infliximab in patients with inflammatory bowel disease on maintenance of intravenous infliximab therapy with or without remission: A multicentre cohort study | Yang, D. H. | Yang, DH | 10 | Univ Ulsan, Coll Med, Asan Med Ctr, Dept Gastroenterol & Internal Med, Seoul, South Korea | ||||||
| One-year clinical outcomes of switching to subcutaneous infliximab in patients with inflammatory bowel disease on maintenance of intravenous infliximab therapy with or without remission: A multicentre cohort study | Ye, B. D. | Ye, BD | 11 | Univ Ulsan, Coll Med, Asan Med Ctr, Dept Gastroenterol & Internal Med, Seoul, South Korea | ||||||
| One-year clinical outcomes of switching to subcutaneous infliximab in patients with inflammatory bowel disease on maintenance of intravenous infliximab therapy with or without remission: A multicentre cohort study | Ye, B. D. | Ye, BD | 11 | Univ Ulsan, Coll Med, Asan Med Ctr, Inflammatory Bowel Dis Ctr, Seoul, South Korea | ||||||
| One-year clinical outcomes of switching to subcutaneous infliximab in patients with inflammatory bowel disease on maintenance of intravenous infliximab therapy with or without remission: A multicentre cohort study | Myung, S. J. | Myung, SJ | 12 | Univ Ulsan, Coll Med, Asan Med Ctr, Dept Gastroenterol & Internal Med, Seoul, South Korea | J-5464-2012 | Myung, Sun-Jung | ||||
| One-year clinical outcomes of switching to subcutaneous infliximab in patients with inflammatory bowel disease on maintenance of intravenous infliximab therapy with or without remission: A multicentre cohort study | Yang, S. K. | Yang, SK | 13 | Univ Ulsan, Coll Med, Asan Med Ctr, Dept Gastroenterol & Internal Med, Seoul, South Korea | ||||||
| One-year clinical outcomes of switching to subcutaneous infliximab in patients with inflammatory bowel disease on maintenance of intravenous infliximab therapy with or without remission: A multicentre cohort study | Yang, S. K. | Yang, SK | 13 | Univ Ulsan, Coll Med, Asan Med Ctr, Inflammatory Bowel Dis Ctr, Seoul, South Korea | ||||||
| One-year clinical outcomes of switching to subcutaneous infliximab in patients with inflammatory bowel disease on maintenance of intravenous infliximab therapy with or without remission: A multicentre cohort study | Kim, E. Y. | Kim, EY | 14 | CCAiD, Crohns & Colitis Assoc Daegu Gyeongbuk, Daegu, South Korea | ||||||
| One-year clinical outcomes of switching to subcutaneous infliximab in patients with inflammatory bowel disease on maintenance of intravenous infliximab therapy with or without remission: A multicentre cohort study | Kim, E. Y. | Kim, EY | 14 | Daegu Catholic Univ, Sch Med, Dept Internal Med, Daegu, South Korea |
페이지 이동: